Patents Assigned to Minu, LLC
-
Patent number: 7341599Abstract: An intraocular lens for modifying the refractive abilities of a natural lens or an existing artificial lens in an eye to correct for vision disorders such as presbyopia, myopia, hyperopia or astigmatism. Specifically, the lens system can be configured so that it does not effect far vision, while effecting near vision using a plus lens to correct for presbyopia. The lens system includes a lens portion and fastening members, with the lens portion being movably secured to at least one of the fastening members so that the position of the lens portion can be modified with respect to the optical axis, and the overall length of the lens system can be increased or decreased.Type: GrantFiled: May 13, 2003Date of Patent: March 11, 2008Assignee: Minu, LLCInventor: Gholam A. Peyman
-
Publication number: 20070142828Abstract: The present invention relates to a system for altering the refractive properties of an eye. The system includes a device configured to be positioned adjacent a portion the cornea of the eye, a cross linker, adapted to be applied to the cornea, a device for emitting ultraviolet rays at the cornea, and a control system configured to monitor the emitting device.Type: ApplicationFiled: February 20, 2007Publication date: June 21, 2007Applicant: Minu, LLCInventor: Gholam Peyman
-
Patent number: 7220224Abstract: The present invention relates to a method of displacing an area of the macula of an eye, including the steps of placing a substance below the surface of the retina, folding the retina to form a folded portion of the retina, and affixing the folded portion, so that the folded portion substantially maintains a folded shape.Type: GrantFiled: July 24, 2003Date of Patent: May 22, 2007Assignee: Minu, LLCInventor: Gholam A. Peyman
-
Patent number: 7147636Abstract: A device for reshaping the cornea to correct the refractive error thereof. A first electrode is adapted to be heated and inserted into the corneal stroma of the eye, thereby reshaping a portion of the cornea. A second electrode is adapted to be heated and inserted into the corneal stroma of the eye, thereby reshaping a portion of the cornea. A member couples the first and the second electrodes together, allowing for change of the refractive power of the cornea, while avoiding irregular shrinkage of the corneal tissue.Type: GrantFiled: September 19, 2002Date of Patent: December 12, 2006Assignee: Minu, LLCInventor: Gholam A. Peyman
-
Patent number: 6942655Abstract: Age-related macular degeneration (AMD) results in the formation of new blood vessels in the eye. The walls of these vessels leak fluid, which causes scarring in the surrounding tissue and results in reduced vision or loss of vision. Photodynamic therapy (PDT) alone has been used to treat AMD, but many retreatments are needed, which cause further damage to the already diseased area. Laser treatment to coagulate the fluid actually causes additional new vessels to form. However, the inventive method of treating patients with both PDT and scatter threshold laser coagulation therapy surprisingly either improved vision, or prevented further loss of vision. Moreover, the combined treatment eliminated the need for retreatment, and did not generate new vessel growth. Threshold laser coagulation and PDT may be administered within the same treatment session or either may be administered first and the other may be administered within ninety days.Type: GrantFiled: March 27, 2002Date of Patent: September 13, 2005Assignee: Minu, LLCInventor: Gholam A. Peyman
-
Patent number: 6936043Abstract: Age-related macular degeneration (AMD) results in the formation of new blood vessels in the eye. The walls of these vessels leak fluid, which causes scarring in the surrounding tissue, resulting in reduced vision or loss of vision. Photodynamic therapy (PDT) alone has been used to treat AMD, but many retreatments are needed, which cause further damage to the already diseased area. Laser treatment to coagulate the fluid actually causes additional new vessels to form. However, the inventive method of treating patients with both PDT and laser coagulation surprisingly either improved vision, or prevented further loss of vision. Moreover, the combined treatment eliminated the need for retreatment, and did not generate new vessel growth. Laser coagulation and PDT may be administered within the same treatment session or either may be administered first and the other may be administered within ninety days.Type: GrantFiled: November 13, 2001Date of Patent: August 30, 2005Assignee: Minu, LLCInventor: Gholam A. Peyman
-
Patent number: 6855163Abstract: A system adapted to modify refractivity of a cornea of an eye, including a first component, and adapted to be implanted at a first depth in the cornea. A second component, separate from the first component, is adapted to be implanted at a second depth in the cornea at a position relative to the first component, such that an axis passing through the eye parallel to the optical axis passes through the second component without passing through the first component. The second depth is closer to the front surface of the cornea than is the first depth.Type: GrantFiled: July 19, 2002Date of Patent: February 15, 2005Assignee: Minu, LLCInventor: Gholam A. Peyman